176 related articles for article (PubMed ID: 30113019)
1. Unfavorably altered plasma clot properties in women with a HERDOO2 score equal to or greater than 2 and prediction of recurrent venous thromboembolism.
Mrozińska S; Cieślik J; Broniatowska E; Undas A
Pol Arch Intern Med; 2018 Oct; 128(10):572-579. PubMed ID: 30113019
[TBL] [Abstract][Full Text] [Related]
2. Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception.
Piróg M; Piwowarczyk S; Undas A
Dis Markers; 2019; 2019():4923535. PubMed ID: 31827635
[TBL] [Abstract][Full Text] [Related]
3. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
4. Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.
Wójcik M; Zaręba L; Undas A
Thromb Res; 2019 Oct; 182():141-149. PubMed ID: 31479942
[TBL] [Abstract][Full Text] [Related]
5. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
Zabczyk M; Plens K; Wojtowicz W; Undas A
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
[TBL] [Abstract][Full Text] [Related]
6. "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?
Rodger MA; Le Gal G; Langlois NJ; Gin B; Mallick R; Giulivi A; Freedman M; Kovacs MJ;
Thromb Res; 2018 Sep; 169():82-86. PubMed ID: 30031290
[TBL] [Abstract][Full Text] [Related]
7. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
[TBL] [Abstract][Full Text] [Related]
8. Unfavourably altered plasma clot properties in patients with primary Raynaud's phenomenon: association with venous thromboembolism.
Żuk J; Snarska-Drygalska A; Malinowski KP; Papuga-Szela E; Natorska J; Undas A
J Thromb Thrombolysis; 2019 Feb; 47(2):248-254. PubMed ID: 30684190
[TBL] [Abstract][Full Text] [Related]
9. Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome.
Siudut J; Grela M; Wypasek E; Plens K; Undas A
J Thromb Haemost; 2016 Apr; 14(4):784-93. PubMed ID: 26786481
[TBL] [Abstract][Full Text] [Related]
10. Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non-recurrent disease.
Baker SR; Zabczyk M; Macrae FL; Duval C; Undas A; Ariëns RAS
J Thromb Haemost; 2019 Apr; 17(4):618-626. PubMed ID: 30725502
[TBL] [Abstract][Full Text] [Related]
11. Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study.
Cieslik J; Mrozinska S; Broniatowska E; Undas A
Blood; 2018 Feb; 131(7):797-807. PubMed ID: 29242187
[TBL] [Abstract][Full Text] [Related]
12. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study.
Aziz D; Skeith L; Rodger MA; Sabri E; Righini M; Kovacs MJ; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther MA; White RH; Le Gal G
J Thromb Haemost; 2021 Jun; 19(6):1526-1532. PubMed ID: 33724705
[TBL] [Abstract][Full Text] [Related]
13. Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.
Goldman S; Frączek P; Szklanny K; Papuga-Szela E; Stanisz A; Undas A
Thromb Haemost; 2018 Apr; 118(4):654-663. PubMed ID: 29618152
[TBL] [Abstract][Full Text] [Related]
14. Altered Fibrin Clot Properties in Patients With Cerebral Venous Sinus Thrombosis: Association With the Risk of Recurrence.
Siudut J; Świat M; Undas A
Stroke; 2015 Sep; 46(9):2665-8. PubMed ID: 26173730
[TBL] [Abstract][Full Text] [Related]
15. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
Drabik L; Wołkow P; Undas A
Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and plasma clot permeability and lysability in patients with venous thromboembolism on rivaroxaban: a cohort study.
Frączek P; Krzysztofik M; Stanisz A; Undas A
Pol Arch Intern Med; 2019 Jun; 129(6):377-385. PubMed ID: 31063157
[TBL] [Abstract][Full Text] [Related]
17. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.
Rodger MA; Le Gal G; Anderson DR; Schmidt J; Pernod G; Kahn SR; Righini M; Mismetti P; Kearon C; Meyer G; Elias A; Ramsay T; Ortel TL; Huisman MV; Kovacs MJ;
BMJ; 2017 Mar; 356():j1065. PubMed ID: 28314711
[No Abstract] [Full Text] [Related]
18. Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome.
Celinska-Löwenhoff M; Zabczyk M; Iwaniec T; Plens K; Musial J; Undas A
Rheumatology (Oxford); 2018 Aug; 57(8):1340-1349. PubMed ID: 29672756
[TBL] [Abstract][Full Text] [Related]
19. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.
Krzek M; Ciesla-Dul M; Zabczyk M; Undas A
Thromb Res; 2012 Oct; 130(4):e216-21. PubMed ID: 22940058
[TBL] [Abstract][Full Text] [Related]
20. Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study.
Polak MW; Siudut J; Plens K; Undas A
J Thromb Thrombolysis; 2019 Nov; 48(4):603-609. PubMed ID: 31432450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
